Takahiro Enjoji

S-1 and CPT-11 Plus Ramucirumab (IRIS+Rmab) as Second-Line Chemotherapy for Patients with Oxaliplatin-Refractory Metastatic Colorectal Cancer (mCRC): A Multicenter Phase II Study in Japan (N-DOCC-F-C-1701).

T. Kuroki, Kazuma Kobayashi, A. Enjoji, 2019, The Kurume medical journal.

Efficacy and Safety of Modified FOLFOXIRI+α in the Treatment of Advanced and Recurrent Colorectal Cancer: A Single-center Experience

Kazuma Kobayashi, S. Eguchi, K. Kanetaka, 2020, Internal medicine.

Long-term survival after conversion surgery for an esophageal neuroendocrine carcinoma: a case report

Shinichiro Kobayashi, K. Kanetaka, Y. Akazawa, 2024, General Thoracic and Cardiovascular Surgery Cases.